MOESM1 of Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children

Additional file 1: Table S1. Bivariate associations between risk factors and the prevalence, molFOB and clinical incidence. Estimates of bivariate associations calculated via generalised estimating equation (GEE) models for prevalence and molecular force of blood-stage (molFOB) infections and negative binomial regression model used for clinical malaria episodes. Recent antimalarial use was not tested in the model for clinical malaria episodes due to aggregated clinical data. aAge in years at enrolment was used for clinical malaria incidence while at the start of interval was used for molFOB. bComparison group; For multilevel variables, comparison group estimates are presented as odds or incidence rate. PCR: Polymerase chain reaction assay; LM: light microscopy; OR: odds ratio; CI95: 95% confidence interval; IRR: incidence rate ratio.

附加文件1：表S1。危险因素与患病率、血液阶段分子流行力（molFOB）及临床发病率之间的双变量关联。其中，患病率与血液阶段分子流行力（molFOB）感染的双变量关联估计值通过广义估计方程（generalised estimating equation, GEE）模型计算，临床疟疾发作的关联估计值则采用负二项回归模型计算。由于临床数据已汇总，临床疟疾发作模型未纳入近期抗疟药物使用情况这一变量。注a：临床疟疾发病率的计算以入组时的年龄（单位：年）为准，而molFOB的计算则以随访间隔起始时的年龄为准。注b：参照组；对于多分类变量，参照组的估计值以比值比（odds ratio, OR）或发病率比（incidence rate ratio, IRR）形式呈现。相关术语说明：聚合酶链式反应（Polymerase chain reaction assay, PCR）；光学显微镜（light microscopy, LM）；95%置信区间（95% confidence interval, CI95）；比值比（odds ratio, OR）；发病率比（incidence rate ratio, IRR）。